NDRA ENDRA Life Sciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NDRA

Price (delayed)

$0.34

Market cap

$3.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.58

Enterprise value

$1.31M

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the ...

Highlights
The company's quick ratio has surged by 104% QoQ and by 9% YoY
The company's EPS has surged by 65% YoY and by 43% QoQ
NDRA's equity is down by 21% year-on-year but it is up by 9% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.endrainc.com
Peers: NWBO

Key stats

What are the main financial stats of NDRA
Market
Shares outstanding
11.04M
Market cap
$3.75M
Enterprise value
$1.31M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.06M
EBITDA
-$9.78M
Free cash flow
-$9.57M
Per share
EPS
-$1.58
Free cash flow per share
-$1.5
Book value per share
$0.67
Revenue per share
$0
TBVPS
$1.06
Balance sheet
Total assets
$6.75M
Total liabilities
$1.1M
Debt
$394,403
Equity
$5.66M
Working capital
$2.13M
Liquidity
Debt to equity
0.07
Current ratio
3.36
Quick ratio
3.14
Net debt/EBITDA
0.25
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-133%
Return on equity
-180.6%
Return on invested capital
-341.4%
Return on capital employed
-171.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NDRA stock price

How has the ENDRA Life Sciences stock price performed over time
Intraday
17.24%
1 week
41.67%
1 month
-7.05%
1 year
-80%
YTD
-83.96%
QTD
-41.38%

Financial performance

How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.52M
Net income
-$10.06M
Gross margin
N/A
Net margin
N/A
ENDRA Life Sciences's net income has increased by 24% YoY and by 15% from the previous quarter
The operating income rose by 20% year-on-year and by 18% since the previous quarter

Growth

What is ENDRA Life Sciences's growth rate over time

Valuation

What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 65% YoY and by 43% QoQ
NDRA's P/B is 88% less than its 5-year quarterly average of 4.0 and 75% less than its last 4 quarters average of 2.0
NDRA's equity is down by 21% year-on-year but it is up by 9% since the previous quarter

Efficiency

How efficient is ENDRA Life Sciences business performance
The return on equity has declined by 36% year-on-year but it has grown by 10% since the previous quarter
The ROA has declined by 21% year-on-year but it has increased by 8% since the previous quarter
The company's return on invested capital rose by 18% YoY and by 17% QoQ

Dividends

What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NDRA.

Financial health

How did ENDRA Life Sciences financials performed over time
The company's quick ratio has surged by 104% QoQ and by 9% YoY
The total liabilities has dropped by 54% since the previous quarter and by 47% year-on-year
The debt is 93% less than the equity
The debt has decreased by 28% YoY and by 9% from the previous quarter
NDRA's equity is down by 21% year-on-year but it is up by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.